DYADIC INTERNATIONAL INC Debt Securities, Held-to-maturity, Allowance for Credit Loss
DYADIC INTERNATIONAL INC (DYAI) had Debt Securities, Held-to-maturity, Allowance for Credit Loss of $0 as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Assets
us-gaap:DebtSecuritiesHeldToMaturityAllowanceForCreditLoss · last filed 2025-05-14
- 2025-03-31: Debt Securities, Held-to-maturity, Allowance for Credit Loss $0.00.
- 2024-12-31: Debt Securities, Held-to-maturity, Allowance for Credit Loss $0.00.
- 2024-09-30: Debt Securities, Held-to-maturity, Allowance for Credit Loss $0.00.
- 2024-06-30: Debt Securities, Held-to-maturity, Allowance for Credit Loss $0.00.
| Period end | Debt Securities, Held-to-maturity, Allowance for Credit Loss |
|---|---|
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 |
| 2024-12-31 | $0.00 10-Q · filed 2025-05-14 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-12 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |